FOXA2 Activates RND1 to Regulate Arachidonic Acid Metabolism Pathway and Suppress Cisplatin Resistance in Lung Squamous Cell Carcinoma. This evidence concerns the gene FOXA2 and squamous cell lung carcinoma.